ANTHEM-TIMI 32 Trial: Anticoagulation With Rnapc2 to Eliminate Mace/TIMI 32

      -Potential Utility of rNAPC2 in ACS: Phase 2 Heparin Replacement Trial Evaluating RNAPc2 in Acute Coronary Syndromes by Dr. Robert P. Giugliano

ESSENCE: The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events

      -Economic Substudy by Dr. Daniel B. Mark

TIMI 11B/ESSENCE Meta-Analysis

      -Enoxaparin for UA/NQMI by Dr. Elliott M. Antman

The Evolving Role of Low Molecular Weight Heparin in ACS

      -An Analysis of Different Trials by Dr. James J. Ferguson

(Return to Contents)

UA / Non STEMI Trials

NICE: National Investigators Collaborating on Enoxaparin-1

      -AntiThrombotic Therapy in the Cath Lab: Preliminary Results from the NICE Trials by Dr. Cindy L. Grines

NICE-3: National Investigators Collaborating on Enoxaparin-3

      -Trial Overview Presented at ESC 2000

NICE-4: National Investigators Collaborating on Enoxaparin-4

      -Safety of Enoxaparin Therapy in Patients Undergoing PCI and Receiving Concomitant Abciximab Therapy

STEEPLE: Safety and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: An International Randomized Evaluation

      -Trial Overview by Dr. Gilles Montalescot (ESC 2005)

      -One-Year Follow-Up by Dr. Gilles Montalescot

SYNERGY: Superior Yield of the New strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors

      -30-day Results by Dr. Kenneth W. Mahaffey and Dr. James J. Ferguson

TIMI 11A and 11B

      -Trial Overviews by Dr. Elliott Antman

(Return to Contents)

STEMI Trials

ExTRACT TIMI-25: Enoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction

      -Trial Overview by Dr. Elliott Antman (ACC 2006)

PCI ExTRACT TIMI-25: PCI in Patients Receiving Enoxaparin or UFH Following Fibrinolytic Therapy for STEMI

      -Study Overview by Dr. C. Michael Gibson et al (AHA 2006)

(Return to Contents)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs